Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Mol Cardio Vasculair from Mol, company number BE0783422676, closed financial year 2025 with a result of € 0 after tax. For that financial year Mol Cardio Vasculair recorded a gross margin of € 163,078 and equity of € 5,040. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 5,040
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 1,659
▼ 99% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 2,418
▲ 87% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 44,127
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 148,770
▲ 20% vs 2024
€ 65,143 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 29,989 | € 58,448 | € 1,932 | € 163,078 | ▲ € 161,146 |
| Equity | € 5,040 | € 5,040 | € 5,040 | € 5,040 | |
| Total debts | € 2,014,048 | € 1,514,114 | € 1,340,731 | € 1,174,705 | ▼ 12% |
| Cash | € 270 | € 3,588 | € 117,771 | € 1,659 | ▼ 99% |
| Bank debt | € 48,327 | € 101,028 | € 123,822 | € 148,770 | ▲ 20% |
| Balance sheet total | € 2,019,088 | € 1,519,154 | € 1,345,771 | € 1,179,745 | ▼ 12% |
Key figures of Mol Cardio Vasculair, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Mol Cardio Vasculair?
What happened at Mol Cardio Vasculair in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Mol. KBO
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2022 to € 0 profit in 2025.
A new publication or filing at Mol Cardio Vasculair? We notify you, reason included.
Follow Mol Cardio VasculairDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Mol Cardio Vasculair are Ruud Koevoets, Massimo Romagnoli, Aydin Basoglu, Henricus Striekwold, Johannes van Asseldonk and Laurent Vande Kerckhove. Ruud Koevoets is also behind Polikliniek Medimol and IMMO MEDIMOL. Massimo Romagnoli is also behind Polikliniek Medimol, IMMO MEDIMOL and DR. M. ROMAGNOLI. Aydin Basoglu is also behind Polikliniek Medimol, Dr. BASOGLU and IMMO MEDIMOL. Henricus Striekwold is also behind IMMO STRIEKWOLD-SIERO, Polikliniek Medimol and IMMO MEDIMOL.
Directors
According to the 2025 annual accounts
Henricus Striekwold
Director
Also active at: IMMO STRIEKWOLD-SIERO, Polikliniek Medimol, IMMO MEDIMOL
Johannes van Asseldonk
Director
Establishments
Establishment units
Physical locations of this company
Gasthuisstraat 1
2400 Mol
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →Heilig Hartziekenhuis Mol
Geneeskundig Genootschap Gewest Mol
Anesthesisten Heilig Hart Ziekenhuis Mol
€ 2,081 gross margin · 2025
Groepspraktijk Orthopedie Mol
Dr. Marlies van der Huizen
€ 180,437 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0783.422.676
- VAT number
- BE 0783.422.676
- Registered office
- Gasthuisstraat 1, 2400 Mol
- Names & denominations
- Mol Cardio Vasculair
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 March 2022
- Peppol
- Not registered
- Contact
- azmol.be
- Activities · NACE
Activiteiten van medisch specialisten
Beroepsopleiding